Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors

Oram, Richard A., McDonald, Timothy J., Shields, Beverley M., Hudson, Michelle M., Shepherd, Maggie H., Hammersley, Suzanne, Pearson, Ewan R., Hattersley, Andrew T. +1 more·2015·Diabetes Care
DOI 10.2337/dc14-0871

Cited by (132)

Items 101–132 of 132

  1. Changing perspectives on the progression of type 1 diabetes
    Noel G. Morgan, Sarah J. Richardson · 2016 · Practical Diabetes
  2. Early- Versus Late-Onset Type 1 Diabetes: Two Different Pathophysiological Subtypes with Implications for Therapy
    Willem M. Kühtreiber, Miriam Davis, Denise Louise Faustman · 2017 · InTech eBooks
  3. Diabetes
    Peter J. Thompson, Anil Bhushan · 2021 · Elsevier eBooks
  4. Study protocol: a randomised controlled proof-of-concept real-world study – does maximising time in range using hybrid closed loop insulin delivery and a low carbohydrate diet restore the glucagon response to hypoglycaemia in adults with type 1 diabetes?
    Faye Baxter, Nicola Baillie, Shareen Forbes · 2022 · BMJ Open
  5. Pathogenesis of Type 1 Diabetes
    Alberto Pugliese · 2018 · Endocrinology
  6. Precision Exercise and Physical Activity for Diabetes
    Normand G. Boulé, Jane Elizabeth Yardley · 2022 · Springer eBooks
  7. Chemical Approaches for Beta-cell Biology
    Amedeo Vetere, Vishal S. Parekh, Ashley E. Modell, Veronika M. Shoba, Amit Choudhary, Bridget K. Wagner · 2022 · Royal Society of Chemistry eBooks
  8. Heterozygous RFX6 protein truncating variants are associated with Maturity-Onset Diabetes of the Young (MODY) with reduced penetrance
    Kashyap A Patel, Jarno L. T. Kettunen, Markku Laakso, Alena Stančáková, Thomas William Laver, Kevin Colclough, Matthew B. Johnson, Marc Abramowicz, Leif Groop, Päivi J. Miettinen et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  9. Reply to Letter to the Editor: Metabolic surgery in morbidly obese patients with type 1 diabetes
    Maud Robert, Pascale Belanger, Frédéric Simon Hould, Simon Marceau, André Tchernof, Laurent D. Biertho · 2015 · Surgery for Obesity and Related Diseases
  10. Metabolic outcomes of islet transplantation and correlation of graft function with hepatic imaging and immune response
    Augustin M. Brooks · 2015
  11. Mediterranean diet and glycaemic control in a Mediterranean population with type 1 diabetes: a pilot study
    Alexis Kyriacou, Josie M. M. Evans, Angelos Kyriacou · 2017 · Endocrine Abstracts
  12. Microvascular Outcomes of Pediatric-Onset Type 1 Diabetes Mellitus: A Single-Center Observational Case Reviews in Sana’a, Yemen
    Abdallah Ahmed Gunaid · 2018 · Clinical Medicine Insights Endocrinology and Diabetes
  13. Long noncoding RNAs are critical regulators of pancreatic islet development and function
    Ruth A. Singer · 2018
  14. A Life-Changing Moment in a Patient with Type 1 Diabetes: Insulin Holiday
    Muhammad Imran Butt, Noha N Mukhtar, Muhammad Riazuddin, Lama Ghassan Amer, Tarek Elsayed · 2020 · Galen Medical Journal
  15. Pediatric Diabetes: Review Article
    B. Bavishna, R. Uma Devi, S. Gopala Krishnan · 2019 · Indian Journal of Public Health Research & Development
  16. Recent Research Findings for Slowly-Progressive Insulin-Dependent Diabetes Mellitus (SPIDDM)
    Hiroshi Bando · 2019 · Institutional Repositories DataBase (IRDB)
  17. Un combustible parcialmente renovable: el biodiesel
    Antonio M. Martin · 2006 · Almirez
  18. Long-term β-cells autoimmune destruction markers persistence and residual C-peptide secretion in type 1 diabetes mellitus
    Рагимов Магомедкерим Разинович, Olga Sergeevna Derevyanko, Н. М. Малышева, Z. T. Zuraeva, Larisa V. Nikankina, Tatiana Vasil'evna Nikonova · 2021 · Diabetes Mellitus
  19. Presentation and Natural History of Type 1 Diabetes
    Augustin M. Brooks · 2022
  20. Brève: Le diabétique reste microsécréteur d’insuline
    2015 · Option/Bio
  21. Faculty Opinions recommendation of Early prediction of autoimmune (type 1) diabetes.
    Carla J. Greenbaum, Sandra M. Lord · 2017 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  22. Circulating C-peptide levels in living children and young people and pancreatic beta cell loss in pancreas donors across type 1 diabetes disease duration
    Carr Alj., Jamie R. J. Inshaw, Flaxman CS, Pia Leete, Rebecca C. Wyatt, Lydia A. Russell, M Palmer, Dmytro Prasolov, Thomas Worthington, Bethany Hull et al. · 2022 · Yearbook of pediatric endocrinology
  23. Long-term persistence of markers of autoimmune β-cell destruction and residual C-peptide secretion in patients from a South American cohort with type 1 diabetes mellitus
    Juan Sebastián Theran León, luis andres dulcey sarmiento, J. Gomez Ayala, Carlos Hernandez, Wiston Rodriguez, Maria Amaya, Maria A. Estevez, Maria Ciliberti, Edgar Blanco, Diego Acevedo et al. · 2023
  24. Les personnes âgées vivant avec un diabète de type 1
    Gaëtan Prévost, Yasmin Dhane, Émilie Merlin · 2023 · Médecine des Maladies Métaboliques
  25. Biochemistry and immunology of inflammation-mediated responses in the development of diabetes mellitus
    Gargi Meur, Roy Anindya, Guy A. Rutter · 2024 · Elsevier eBooks
  26. C-Peptid als Surrogatparameter einer residualen Beta-Zellfunktion bei Typ-1-Diabetes und ihre mögliche klinische Bedeutung
    Dirk Müller‐Wieland, Martin Miszon, Désirée Dunstheimer, Thomas M. Forst, Thomas Michael Kapellen, Oliver Schnell, Monika Kellerer · 2024 · Diabetologie und Stoffwechsel
  27. Additional file 1 of Changes to the identity of EndoC-βH1 beta cells may be mediated by stress-induced depletion of HNRNPD
    Nicola M. Jeffery, David J. Chambers, Invergo, Brandon M., Ryan M. Ames, Harries, Lorna W. · 2021 · Figshare
  28. Les cellules MAIT dans le diabète de type 1 chez l'homme
    Isabelle Nel · 2019 · theses.fr (ABES)
  29. Syntaxin-4, a key exocytosis mediating protein, shows heterogeneous expression in insulin-positive cells of human donors with new-onset and longer duration of type 1 diabetes: comparison with non-diabetic autoantibody-positive and -negative donors
    Joshua Potman, Kevin Xueying Sun, Kaaj Pala, Lars Krogvold, Knut Dahl‐Jørgensen, Shiva Reddy · 2026 · Journal of Molecular Histology
  30. Stage‐Adapted Disease‐Modifying Therapy in Type 1 Diabetes
    Chenming Ye, Zhenning Jin, Shen S. Hu · 2026 · Diabetes Obesity and Metabolism
  31. Clinical Utility of a Type 1 Diabetes Genetic Risk Score Measured as Part of MODY Genetic Testing
    Jacques Murray Leech, Aparajita Sriram, Kevin Colclough, Andrew Tym Hattersley, Jayne Houghton, Thomas W. Laver, Kashyap Amratlal Patel · 2026 · Diabetes Care
  32. Three-Year Glycemic Trajectories in Subgroups With Type 1 Diabetes at Risk for Suboptimal Glycemic Control: A Multicenter Continuous Glucose Monitoring Study
    Jee Hee Yoo, Seohyun Kim, Y.J. Park, Soojin Park, Choon Hee Chung, Jae Hyeon Kim, Soo Heon Kwak, Gyuri Kim · 2026 · Diabetes Care